Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized adjuvant TAP-144-SR (3M) in premenopausal breast cancer
jRCT1080221276Phase 4
- Sponsor
- Takeda
- Start
- Oct 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of leuprolide in breast cancer (2 arms), sponsored by Takeda.
02
Drugs
leuprolide
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT1080221276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221276.